214 related articles for article (PubMed ID: 24706389)
41. Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care?
Nathwani D; Rubinstein E; Barlow G; Davey P
Clin Infect Dis; 2001 Mar; 32(5):728-41. PubMed ID: 11229840
[TBL] [Abstract][Full Text] [Related]
42. Economic burden of acute lower respiratory tract infection in South African children.
Sinha A; Kim S; Ginsberg G; Franklin H; Kohberger R; Strutton D; Madhi SA; Griffiths UK; Klugman KP
Paediatr Int Child Health; 2012 May; 32(2):65-73. PubMed ID: 22595212
[TBL] [Abstract][Full Text] [Related]
43. [Health impact and treatment costs of community-acquired pneumonia in children in the first level of public attention in Argentina].
Bernztein R; Drake I
Arch Argent Pediatr; 2009 Apr; 107(2):101-10. PubMed ID: 19452081
[TBL] [Abstract][Full Text] [Related]
44. [Comparison of outpatient and inpatient costs of moderate and severe exacerbations of chronic obstructive pulmonary disease in Poland].
Jahnz-Rózyk K; Targowski T; From S
Pneumonol Alergol Pol; 2008; 76(6):426-31. PubMed ID: 19173191
[TBL] [Abstract][Full Text] [Related]
45. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
[TBL] [Abstract][Full Text] [Related]
46. National estimates of the inpatient burden of pediatric bipolar disorder in the United States.
Berry EA; Heaton PT; Kelton CM
J Ment Health Policy Econ; 2011 Sep; 14(3):115-23. PubMed ID: 22116169
[TBL] [Abstract][Full Text] [Related]
47. Costs of admission for paediatric pneumonia in a setting of human immunodeficiency virus infection.
Kitchin OP; Wessels F; Masekela R; Becker P; Green RJ
Int J Tuberc Lung Dis; 2011 Dec; 15(12):1702-7. PubMed ID: 22118183
[TBL] [Abstract][Full Text] [Related]
48. Private costs of patients hospitalized with community-acquired pneumonia.
Jacobs P; Marrie TJ; Calder P
Can Respir J; 2005; 12(4):205-8. PubMed ID: 16003457
[TBL] [Abstract][Full Text] [Related]
49. Work-related and health care cost burden of community-acquired pneumonia in an employed population.
Kleinman NL; Yu H; Beren IA; Sato R
J Occup Environ Med; 2013 Oct; 55(10):1149-56. PubMed ID: 24064787
[TBL] [Abstract][Full Text] [Related]
50. Economic and demographic consequences of AIDS in Namibia: rapid assessment of the costs.
Ojo K; Delaney M
Int J Health Plann Manage; 1997; 12(4):315-26. PubMed ID: 10177418
[TBL] [Abstract][Full Text] [Related]
51. Hospitalization costs of adult community-acquired pneumonia in England.
Campling J; Wright HF; Hall GC; Mugwagwa T; Vyse A; Mendes D; Slack MPE; Ellsbury GF
J Med Econ; 2022; 25(1):912-918. PubMed ID: 35726515
[TBL] [Abstract][Full Text] [Related]
52. The effects of incorporating a pneumonia severity index into the admission protocol for community-acquired pneumonia.
Jo S; Kim K; Jung K; Rhee JE; Cho IS; Lee CC; Singer AJ
J Emerg Med; 2012 Feb; 42(2):133-8. PubMed ID: 20542398
[TBL] [Abstract][Full Text] [Related]
53. Incidence of pediatric traumatic brain injury and associated hospital resource utilization in the United States.
Schneier AJ; Shields BJ; Hostetler SG; Xiang H; Smith GA
Pediatrics; 2006 Aug; 118(2):483-92. PubMed ID: 16882799
[TBL] [Abstract][Full Text] [Related]
54. [Preliminary assessment of Streptococcus pneumoniae, pneumonia, economical and clinical burden in Romania].
Stoicescu IP; Mihăescu T; Azoicăi D; Aramă V; Bâlcu I
Pneumologia; 2007; 56(3):118-23. PubMed ID: 18019971
[TBL] [Abstract][Full Text] [Related]
55. Differences in the use of health resources by Spanish and immigrant HIV-infected patients.
Velasco M; Castilla V; Guijarro C; Moreno L; Barba R; Losa JE
Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):458-62. PubMed ID: 22377495
[TBL] [Abstract][Full Text] [Related]
56. A randomized controlled trial of hospital versus home based therapy with oral amoxicillin for severe pneumonia in children aged 3 - 59 months: The IndiaCLEN Severe Pneumonia Oral Therapy (ISPOT) Study.
Patel AB; Bang A; Singh M; Dhande L; Chelliah LR; Malik A; Khadse S;
BMC Pediatr; 2015 Nov; 15():186. PubMed ID: 26577943
[TBL] [Abstract][Full Text] [Related]
57. Cost of hospitalizing children with invasive pneumococcal pneumonia.
Brotons P; Gelabert G; Launes C; Sicuri E; Pallares R; Muñoz-Almagro C
Vaccine; 2013 Feb; 31(7):1117-22. PubMed ID: 23262168
[TBL] [Abstract][Full Text] [Related]
58. Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia.
Fine MJ; Pratt HM; Obrosky DS; Lave JR; McIntosh LJ; Singer DE; Coley CM; Kapoor WN
Am J Med; 2000 Oct; 109(5):378-85. PubMed ID: 11020394
[TBL] [Abstract][Full Text] [Related]
59. Hospitalized low-risk community-acquired pneumonia: outcome and potential for cost-savings.
Hoe LK; Keang LT
Respirology; 1999 Sep; 4(3):307-9. PubMed ID: 10489681
[TBL] [Abstract][Full Text] [Related]
60. Direct costs in patients hospitalised with community-acquired pneumonia after non-response to outpatient treatment with macrolide antibacterials in the US.
Paladino JA; Adelman MH; Schentag JJ; Iannini PB
Pharmacoeconomics; 2007; 25(8):677-83. PubMed ID: 17640109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
